In hemangioendothelioma cells, ART time- and dose-dependently reduced tumor cell growth, concomitantly decreasing the expression of VEGF-A, VEGFR1, VEGFR2, and HIF-1α [46]. The gene discussed is FLT1; the disease is hemangioendothelioma.